The effectiveness of oral Tranexamic Acid on prevention of rebleeding in patients with acute upper gastrointestinal bleeding
Phase 3
Recruiting
- Conditions
- Acute Upper Gastrointestinal Bleeding.
- Registration Number
- IRCT20190116042380N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 375
Inclusion Criteria
Patients With Acute Upper Gastrointestinal Bleeding
Exclusion Criteria
Patient's discontent
Clean base Ulcers in Endoscopy
Malignant Ulcers in Endoscopy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gastrointestinal Bleeding. Timepoint: one, Two and Three Days After Drug Consumption. Method of measurement: Hemoglubin Drop, Gastrointestinal Rebleeding.
- Secondary Outcome Measures
Name Time Method Hemoglobin Drop. Timepoint: Gastrointestinal Rebleeding. Method of measurement: Serial Hemoglobin measurement.